Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) has been associated with the metabolic syndrome. However, it is not clear whether insulin resistance is an independent feature of NAFLD, and it remains to be determined which of the in vivo actions of insulin are impaired in this condition.Methods We performed a two-step (1.5 and 6 pmol min(-1) kg(-1)) euglycaemic insulin clamp coupled with tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) and indirect calorimetry in 12 non-obese, normolipidaemic, normotensive, non-diabetic patients with biopsy-proven NAFLD and six control subjects.Results In NAFLD patients, endogenous glucose production (basal and during the clamp) was normal; however, peripheral glucose disposal was markedly decreased (by 30% and 45% at the low and high insulin doses, respectively, p<0.0001) at higher plasma insulin levels (p=0.05), due to impaired glucose oxidation (p=0.003) and glycogen synthesis (p<0.001). Compared with control subjects, glycerol appearance and lipid oxidation were significantly increased in NAFLD patients in the basal state, and were suppressed by insulin to a lesser extent (p<0.05-0.001). The lag phase of the in vitro copper-catalysed peroxidation of LDL particles was significantly shorter in the patients than in the control subjects (48+/-12 vs 63+/-13 min, p<0.04). Lipid oxidation was significantly related to endogenous glucose production, glucose disposal, the degree of hepatic steatosis, and LDL oxidisability.Conclusions/interpretation Insulin resistance appears to be an intrinsic defect in NAFLD, with the metabolic pattern observed indicating that adipose tissue is an important site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, many studies have shown an increase in fatty acid oxidation and β-hydroxybutyrate in individuals with MASH compared to those without liver steatosis.,38,39 likely driven by the high fatty acid flux to the liver due to Adipo-IR.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Self-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Self-citation
Cited by
Items 301–400 of 790
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 46
Self-citationPatel, A. H., Peddu, D. K., Amin, S., Elsaid, M. I., Minacapelli, C. D., Chandler, T.-M., Catalano, C., & Rustgi, V. K. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00204 · Cited by 47
Wang, D. Q. ‐., Portincasa, P., & Neuschwander‐Tetri, B. A. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130001 · Cited by 46
Steatosis and Steatohepatitis: Complex Disorders
Bettermann, K., Hohensee, T., & Haybaeck, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069924 · Cited by 48
Li, T., Feng, R. M., Zhao, C., Wang, Y., Wang, J., Liu, S., Cao, J., Wang, H., Wang, T., Guo, Y., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6742 · Cited by 41
Liu, S., Yuan, J.-T., Yue, W., Bi, Y., Shen, X., Gao, J., Xu, X. Y., & Lu, Z. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.012 · Cited by 42
Implications of Elevated Serum Alanine Aminotransferase Levels: Think Outside the Liver
Ioannou, G. N. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.11.005 · Cited by 46
How effective are lifestyle changes in the prevention of type 2 diabetes mellitus?
Pi-Sunyer, F. X. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00287.x · Cited by 40
Stättermayer, A. F., Traussnigg, S., Aigner, E. S., Kienbacher, C., Huber-Schönauer, U., Steindl‐Munda, P., Stadlmayr, A., Wrba, F., Trauner, M., Datz, C., et al. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.08.006 · Cited by 40
Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice
Harvey, I. C., Stephenson, E. J., Redd, J. R., Tran, Q. T., Hochberg, I., Qi, N., & Bridges, D. (2018) · Endocrinology · doi:10.1210/en.2018-00147 · Cited by 45
Sung, M. J., Lim, T. S., Jeon, M. Y., Lee, H. W., Kim, B. K., Kim, D. Y., Ahn, S. H., Han, K., Park, J. Y., & Kim, S. U. (2020) · Gut and Liver · doi:10.5009/gnl19126 · Cited by 41
Fakhoury-Sayegh, N., Trak-Smayra, V. E., Khazzaka, A., Esseily, F., Obeid, O., Lahoud-Zouein, M., & Younes, H. (2015) · Nutrition Research and Practice · doi:10.4162/nrp.2015.9.4.350 · Cited by 40
Asai, A., Chou, P. M., Bu, H., Wang, X., Rao, M. S., Jiang, A., DiDonato, C. J., & Tan, X. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00291.2013 · Cited by 42
Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease
Poulsen, M. K., Nellemann, B., Stødkilde-Jørgensen, H., Pedersen, S. B., Grønbæk, H., & Nielsen, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3476 · Cited by 39
Incretin based therapies: A novel treatment approach for non-alcoholic fatty liver disease
Blaslov, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7356 · Cited by 38
Mohammad, A., Yusof, B. N. M., Hanipah, Z. N., Sabran, M. R., Yusof, L. M., & Khosroshahi, M. Z. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102273 · Cited by 39
Fathi, M., Alavinejad, P., Haidari, Z., & Amani, R. (2020) · Biological Trace Element Research · doi:10.1007/s12011-019-02015-8 · Cited by 39
Hashimoto, Y., Hamaguchi, M., Tanaka, M., Obora, A., Kojima, T., & Fukui, M. (2018) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2017.12.003 · Cited by 42
Athyros, V. G., Τζιόμαλος, Κ., Daskalopoulos, G. N., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.561363 · Cited by 39
Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM
Colosimo, S., Mitra, S. K., Chaudhury, T., & Marchesini, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111016 · Cited by 38
Dietary pattern and hepatic lipid metabolism
Zou, P., & Wang, L. (2023) · Liver Research · doi:10.1016/j.livres.2023.11.006 · Cited by 43
Foo, R. M. C., Junyi, J., Du, R., Goh, G. B., Chong, Y. S., Zhang, C., & Li, L. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102609 · Cited by 44
Chon, Y. E., Kim, K. J., Jung, K. S., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Chon, C. Y., Chung, J. B., Park, K. H., et al. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.4.885 · Cited by 42
van der Graaff, D., Kwanten, W. J., & Francque, S. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.11.014 · Cited by 39
Kim, H. S., Cho, Y. K., Kim, E. H., Lee, M. J., Jung, C. H., Park, J., Kim, H., & Lee, W. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010041 · Cited by 39
Li, R., Li, Y., Yang, X., Yu, H., Yu, H., & Li, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03540-2 · Cited by 40
Holmer, M., Ekstedt, M., Nasr, P., Zenlander, R., Wester, A., Tavaglione, F., Romeo, S., Kechagias, S., Stål, P., & Hagström, H. (2022) · Liver International · doi:10.1111/liv.15438 · Cited by 38
Li, M., Cui, M., Li, G., Liu, Y., Xu, Y., Eftekhar, S. P., & Ala, M. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2266-1503 · Cited by 37
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
Manilla, V., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15112521 · Cited by 39
Kamath, S., Chávez, A. O., Gastaldelli, A., Casiraghi, F., Halff, G. A., ABRAHAMIAN, G. A., Davalli, A. M., Bastarrachea, R. A., Comuzzie, A. G., Guardado‐Mendoza, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027617 · Cited by 40
Self-citationRole of ketone signaling in the hepatic response to fasting
Geisler, C. E., Ghimire, S., Bogan, R. L., & Renquist, B. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00415.2017 · Cited by 39
Dhurandhar, E. J., Krishnapuram, R., Hegde, V. K., Dubuisson, O. S., Tao, R., Dong, X. C., Ye, J., & Dhurandhar, N. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047813 · Cited by 37
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
Vitulo, M., Gnodi, E., Rosini, G., Meneveri, R., Giovannoni, R., & Barisani, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612748 · Cited by 37
Sabatini, S., Sen, P., Carli, F., Pezzica, S., Rosso, C., Lembo, E., Verrastro, O., Daly, A. K., Govaere, O., Cockell, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101820 · Cited by 45
Self-citationSaely, C. H., Vonbank, A., Rein, P., Woess, M., Beer, S., Aczél, S., Jankovic, V., Boehnel, C., Risch, L., & Drexel, H. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.07.024 · Cited by 36
Biagioli, M., & Fiorucci, S. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.003 · Cited by 37
Association between metabolic syndrome and liver histology among NAFLD patients without diabetes
Kanwar, P., Nelson, J. E., Yates, K. P., Kleiner, D. E., Ünalp–Arida, A., & Kowdley, K. V. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000114 · Cited by 35
Oligonucleotide therapies for nonalcoholic steatohepatitis
Li, S., Xiong, F., Zhang, S., Liu, J., Gao, G., Xie, J. H., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102184 · Cited by 35
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum
Vidal‐Cevallos, P., Sorroza-Martínez, A. P., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084397 · Cited by 37
Sangouni, A. A., Ghavamzadeh, S., & Jamalzehi, A. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.013 · Cited by 36
Charatcharoenwitthaya, P., Karaketklang, K., & Aekplakorn, W. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13001 · Cited by 34
Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge
Thomas, J. J., & Ren, J. T. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12024 · Cited by 39
Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients?
Paulino, T. L., Rafael, M. N., Hix, S., Shigueoka, D. C., Ajzen, S., Kochi, C., Suano-Souza, F. I., da Silva, R., Costa‐Carvalho, B. T., & Sarni, R. O. S. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0689-y · Cited by 37
Rattarasarn, C. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2005.01521.x · Cited by 37
The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients
Cetin, E. G., Demir, N., & Sen, I. (2018) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2018.83604 · Cited by 38
Nonalcoholic Fatty Liver Disease Markers Are Associated with Insulin Resistance in Type 1 Diabetes
Bulum, T., Kolarić, B., Duvnjak, L. S., & Duvnjak, M. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1807-7 · Cited by 38
Hanafi, M. Y., Zaher, E. M., El‐Adely, S., Sakr, A., Ghobashi, A. H., Hemly, M., Kazem, A. H., & Kamel, M. A. E.-N. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6028 · Cited by 38
Rebelos, E., Iozzo, P., Guzzardi, M. A., Brunetto, M. R., & Bonino, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i30.4999 · Cited by 33
Why Does NAFLD Predict Type 2 Diabetes?
Lattuada, G., Ragogna, F., & Perseghin, G. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0190-2 · Cited by 38
Liu, Y., Liao, L., Chen, Y., & Han, F. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10139 · Cited by 35
Insulin resistance, adipose depots and gut: Interactions and pathological implications
Gastaldelli, A., Natali, A., Vettor, R., & Corradini, S. G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.013 · Cited by 46
Self-citationThe diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 34
Moore, M. P., Shryack, G. E., Alessi, I. G., Wieschhaus, N., Meers, G. M.-E., Johnson, S. A., Wheeler, A. A., Ibdah, J. A., Parks, E. J., & Rector, R. S. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00336.2023 · Cited by 34
Pathophysiology of Non-Alcoholic Steatohepatitis and Basis for Treatment
Pinzani, M. (2011) · Digestive Diseases · doi:10.1159/000323928 · Cited by 33
IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome.
Mallea-Gil, S., Ballarino, M. C., Spiraquis, A., Iriarte, M., Kura, M., Gimenez, S., Oneto, A., Guitelman, M. A., Machado, R. A., & Miguel, C. M. (2012) · PubMed · Cited by 33
Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?
Singh, S. P., Misra, B., Kar, S. K., Panigrahi, M. K., Misra, D., Bhuyan, P., Pattnaik, K., Meher, C., Agrawal, O., Rout, N., et al. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.08.014 · Cited by 31
Non-alcoholic fatty liver disease (NAFLD) - A novel common aspect of the metabolic syndrome
Bogdanová, K., Poczatková, H., Uherková, L., Riegrová, D., Rypka, M., Fehér, J., Marchesini, G., & Veselý, J. (2006) · Biomedical Papers · doi:10.5507/bp.2006.014 · Cited by 37
Farage, A. E., Abdo, W. S., Osman, A., Abdel‐Kareem, M. A., Hakami, Z. H., Alsulimani, A., Bin‐Ammar, A., Alanazi, A. S., Alsuwayt, B., Alanazi, M. M., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121688 · Cited by 30
Gallstone Disease in Cirrhosis—Pathogenesis and Management
Mallick, B., & Anand, A. C. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.09.011 · Cited by 30
Nonalcoholic steatohepatitis in nonobese patients: Not so different after all
Cusi, K. J. (2016) · Hepatology · doi:10.1002/hep.28839 · Cited by 30
A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity
Osorio-Conles, Ó., Vega‐Beyhart, A., Ibarzábal, A., Balibrea, J. M., Graupera, I., Rimola, J., Vidal, J., & de Hollanda, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910541 · Cited by 34
Badran, H. M., Elsabaawy, M., Sakr, A., Eltahawy, M., Elsayed, M. M., Elsabaawy, D. M., & Abdelkreem, M. (2022) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2022.115056 · Cited by 29
Lee, S., Rivera-Vega, M., Alsayed, H. M. A. A., Boesch, C., & Libman, I. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12141 · Cited by 32
Matafome, P. N., Nunes, E., Louro, T. M., Amaral, C. P., Crisóstomo, J., Rodrigues, L., Moedas, A. R., Monteiro, P. F., Cipriano, A., & Seiça, R. M. F. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0363-y · Cited by 29
Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
Richart, C., Auguet, T., & Terra, X. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1005265 · Cited by 30
Russo, M. F., Lembo, E., Mari, A., Angelini, G., Verrastro, O., Nanni, G., Pompili, M., Raffaelli, M., Vecchio, F. M., Bornstein, S. R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa892 · Cited by 28
A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach
Sangouni, A. A., & Ghavamzadeh, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.063 · Cited by 31
Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
Ota, T. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-7360-6_20 · Cited by 28
Hendawy, A. S., El-Lakkany, N. M., Mantawy, E. M., Hammam, O. A., Botros, S. S., & El‐Demerdash, E. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120695 · Cited by 28
Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution
Bozzetto, L., Prinster, A., Mancini, M., Giacco, R., Natale, C. D., Salvatore, M., Riccardi, G., Rivellese, A. A., & Annuzzi, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02372.x · Cited by 34
Sasaki, R., Yano, Y., Yasuma, T., Onishi, Y., Suzuki, T., Maruyama-Furuta, N., Gabazza, E. C., Sumida, Y., & Takei, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.4100 · Cited by 30
Pennisi, G., Celsa, C., Spatola, F., Dallio, M., Federico, A., & Petta, S. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16224334 · Cited by 34
Costabile, G., Della Pepa, G., Salamone, D., Luongo, D., Naviglio, D., Brancato, V., Cavaliere, C., Salvatore, M., Cipriano, P., Vitale, M., et al. (2022) · Nutrients · doi:10.3390/nu14102178 · Cited by 27
“Individuals with NAFLD may have lower [29], similar [30], or higher [31] plasma β-hydroxybutyrate concentrations than individuals without NAFLD.”
BackgroundThe Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis
Clanton, J., & Subichin, M. P. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.03.008 · Cited by 27
Caviglia, G. P., Rosso, C., Armandi, A., Gaggini, M., Carli, F., Abate, M. L., Olivero, A., Ribaldone, D. G., Saracco, G. M., Gastaldelli, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228838 · Cited by 28
Self-citationMannucci, E., Monami, M., & Rotella, C. M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.09.003 · Cited by 28
Nuala M Byrne, I. J. H. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000300 · Cited by 28
Hossain, I. A., Akter, S., Rahman, M. K., & Ali, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142165 · Cited by 28
Dongiovanni, P., & Valenti, L. V. C. (2013) · PPAR Research · doi:10.1155/2013/452061 · Cited by 27
Marjot, T., Smith, K., Westcott, F., White, S., Johnson, E. M., Srnic, N., Barrett, A., Hall, E., Gralton, K., Dennis, K. M. J. H., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2025.12.004 · Cited by 30
Coccia, F., Testa, M., Guarisco, G., Cristofano, C. D., Silecchia, G., Leonetti, F., Gastaldelli, A., & Capoccia, D. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.08.001 · Cited by 27
Self-citationZhai, T., Xu, W., Liu, Y., Qian, K., Xiong, Y., & Chen, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2313641 · Cited by 30
Salidroside in the Treatment of NAFLD/NASH
Qu, B., Liu, X., Liang, Y., Zheng, K., Zhang, C., & Lu, L. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200401 · Cited by 26
Kang, Y. H., Min, H., Kim, I. J., Kim, Y. K., & Son, S. M. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-077 · Cited by 29
Catanzaro, R., SELVAGGIO, F., Sciuto, M., Zanoli, L., Yazdani, A., He, F., & Marotta, F. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02818-x · Cited by 27
Apostolov, R., Gianatti, E., Wong, D. J., Kutaiba, N., Gow, P. J., Grossmann, M., & Sinclair, M. J. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i4.754 · Cited by 25
Portillo-Sánchez, P., Yavuz, S., Bril, F., & Cusi, K. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0229-3 · Cited by 26
Macfarlane, D. P., Raubenheimer, P. J., Preston, T., Gray, C. D., Bastin, M. E., Marshall, I., Iredale, J. P., Andrew, R., & Walker, B. R. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00030.2014 · Cited by 25
Li, M., Zhang, S., Wu, Y., Ye, J., Cao, X., Liu, J., Sun, Y., & Zhong, B. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3564-5 · Cited by 26
Ghrelin-ghrelinO-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease
Zhang, S., & Fan, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i11.3214 · Cited by 25
Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
Shigiyama, F., Kumashiro, N., Furukawa, Y., Funayama, T., Takeno, K., Wakui, N., Ikehara, T., Nagai, H., Taka, H., Fujimura, T., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1077 · Cited by 25
Wang, X., Zhang, X., & Ma, L. (2018) · Medicine · doi:10.1097/md.0000000000010605 · Cited by 26
Papaetis, G. S. (2021) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2021.105314 · Cited by 25
Rigal, S., Casas, B., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Müllers, E., Karlsson, F. H., Clausen, M., Hansson, S., Leonard, L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06514-w · Cited by 24
Metabolic determinants of NAFLD in adults with type 1 diabetes
Serdarova, M. S., Dimova, R. B., Chakarova, N. Y., Grozeva, G. G., Todorova, A., Tsarkova, P., Marinova, C., Popov, D., Mateva, L., & Tankova, T. I. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109819 · Cited by 24
Zuo, Q., Park, N. H., Lee, J. K., Casiano, A. S., & Madak‐Erdogan, Z. (2023) · Steroids · doi:10.1016/j.steroids.2023.109330 · Cited by 27
Growth differentiation factor 15: Emerging role in liver diseases
Li, Y., Zhang, J., Chen, S., Ke, Y., Ke, Y., & Chen, Y. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156727 · Cited by 24
Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease
Suh, J.-B., Kim, S. M., Cho, G.-J., & Choi, K. M. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.836754 · Cited by 25
The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis
Carvalho, J. A. M., Barengo, N. C., Tuomilehto, J. O., Conceição, R., & Santos, R. D. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.554428 · Cited by 27
Salman, M. S. K., Kamel, M. A. E.-N., El‐Nabi, S. H., Ismail, A. H. A., Ullah, S., Al-Ghamdi, A. K., Hathout, H. M. R., & El‐Garawani, I. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265455 · Cited by 23
Retracted
Metadata
- Authors
- Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M.
- Affiliations
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- University of Pisa (IT)
- Corresponding author
- Bugianesi, E.
- Venue
- Diabetologia
- Published
- 2005-03-04
- Volume
- 48
- Issue
- 4
- Pages
- 634-642
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1975388439
- Cited by
- 770
- References
- 63
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 42 · 2023: 48 · 2022: 47 · 2021: 48 · 2020: 51 · 2019: 40 · 2018: 43 · 2017: 46 · 2016: 49 · 2015: 37 · 2014: 40 · 2013: 35 · 2012: 32
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, glucose oxidation, hepatic glycogen synthesis, lipid oxidation, hepatic steatosis, adipose tissue, non-diabetic patients
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Body Composition, C-Peptide, Calorimetry, Indirect, Enzymes, Fasting, Fatty Acids, Nonesterified, Fatty Liver, Glucose, Glycerol, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, LDL, Liver, Male, Middle Aged, Oxidation-Reduction, Glucose Clamp Technique, 3-Hydroxybutyric Acid, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.